![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
Preview |
PDF (Supplementary Material)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
91kB |
| Item Type: | Article |
|---|---|
| Title: | Opposite macrophage polarization in different subsets of ovarian cancer: observation from a pilot study |
| Creators Name: | Vankerckhoven, A., Wouters, R., Mathivet, T., Ceusters, J., Baert, T., Van Hoylandt, A., Gerhardt, H., Vergote, I. and Coosemans, A. |
| Abstract: | The role of the innate immune system in ovarian cancer is gaining importance. The relevance of tumor-associated macrophages (TAM) is insufficiently understood. In this pilot project, comprising the immunofluorescent staining of 30 biopsies taken from 24 patients with ovarian cancer, we evaluated the presence of total TAM (cluster of differentiation (CD) 68 expression), M1 (major histocompatibility complex (MHC) II expression), and M2 (anti-mannose receptor C type 1 (MRC1) expression), and the blood vessel diameter. We observed a high M1/M2 ratio in low-grade ovarian cancer compared to high-grade tumors, more total TAM and M2 in metastatic biopsies, and a further increase in total TAM and M2 at interval debulking, without beneficial effects of bevacizumab. The blood vessel diameter was indicative for M2 tumor infiltration (Spearman correlation coefficient of 0.65). These data mainly reveal an immune beneficial environment in low-grade ovarian cancer in contrast to high-grade serous ovarian cancer, where immune suppression is not altered by neoadjuvant therapy. |
| Keywords: | Ovarian Cancer, Macrophages, M2 |
| Source: | Cells |
| ISSN: | 2073-4409 |
| Publisher: | MDPI |
| Volume: | 9 |
| Number: | 2 |
| Page Range: | 305 |
| Date: | 27 January 2020 |
| Official Publication: | https://doi.org/10.3390/cells9020305 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
